Current rheumatology reviews
Factors Determining the Switch of the First Biological Treatment in Spondyloarthritis: Data from the RBSMR Registry.
Oumaima Idrissi Ouali, Imane El Mezouar, Nessrine Akasbi, Salma Mikou, Moncef Maiouak, Ihssane Hmamouchi, Redouane Abouqal, Ahmed Bezza, Fadoua Allali, Rachid Bahiri, Imane El Bouchti, Imad Ghozlani, Hasna Hassikou, Linda Ichchou, Saadia Janani
Published: 202610.2174/0115733971396081251103030150
Abstract
INTRODUCTION: Despite the substantial progress made in the therapeutic management of spondylarthritis (SpA) after the advent of biotherapy, some patients still undergo, for various reasons, therapeutic switches to an alternative biological agent. Thi…
Preview only. Read the full abstract at the source